• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON PEN II ORGANON PUREGON® PEN SECOND GEN; PEN NEEDLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON PEN II ORGANON PUREGON® PEN SECOND GEN; PEN NEEDLE Back to Search Results
Catalog Number 47289378
Device Problem Inaccurate Delivery (2339)
Patient Problem Underdose (2542)
Event Date 06/06/2018
Event Type  Injury  
Manufacturer Narrative
Unknown manufacturer: there are multiple bd locations where this unspecified bd device may have been manufactured.A catalog and lot number could not be confirmed for this incident and without this information we are unable to determine where the device was manufactured.Therefore, bd corporate headquarters in (b)(4) has been listed in sections and the (b)(4) fda registration number has been used for the manufacture report number.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that after the patient had completed six doses of "follitropin beta" with the pen ii organon puregon® pen second gen, the pen injector "still had 2/3rds of the medication in it (underdose)".The patient "did not respond to the drug and failed their cycle", but it was reported that "the outcome of the event was unknown", and "the casualty was not provided".
 
Event Description
It was reported that after the patient had completed six doses of "follitropin beta" with the pen ii organon puregon® pen second gen, the pen injector "still had 2/3rds of the medication in it (underdose)".The patient "did not respond to the drug and failed their cycle", but it was reported that "the outcome of the event was unknown", and "the casualty was not provided".
 
Manufacturer Narrative
Investigation summary: zero (0) samples were provided to bd medical ¿ pharmaceutical system (bdm-ps) for analysis.Bdm-ps performed a batch history record¿s review (bhr) including a review of all data collected during in process and quality inspections.The batch involved in this complaint meets all acceptable quality levels (aql¿s), was manufactured and released according to applicable procedures and specifications.Since the sample was not received, investigation cannot be performed as a sample is required to investigate further.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PEN II ORGANON PUREGON® PEN SECOND GEN
Type of Device
PEN NEEDLE
Manufacturer (Section D)
BECTON DICKINSON
1 becton drive
franklin lakes NJ 07417
MDR Report Key8199488
MDR Text Key131503379
Report Number2243072-2018-01912
Device Sequence Number1
Product Code FMI
Combination Product (y/n)N
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,other
Type of Report Initial,Followup
Report Date 01/16/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/27/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Catalogue Number47289378
Device Lot Number15120006
Was Device Available for Evaluation? No
Date Manufacturer Received06/22/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age32 YR
-
-